Institution profile

弘前大学医学部附属病院

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 03B2607015 +2

Location

Prefecture
Aomori
Address
弘前市本町53

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 特定非営利活動法人先端医療推進機構 特定認定再生医療等委員会名古屋
  • 国立大学法人弘前大学認定再生医療等委員会

Public score

52.7/ 100

A · Review level
25.0 / 30
B · Technologies
15.9 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
4.6 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 403of 1736

Registered technologies
3
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 52.7
Public score →100

Registered technologies (3)

PRP and platelet-derived 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家多血小板血漿(Arthrex ACP Double Syringe Systemにより作製)、自家多血小板血漿(ACP MAX PRPシステムにより作製)、または自家多血小板血漿(Angel cPRPシステムにより作製)+ヒアルロン酸併用療法を用いた関節内組織損傷に対する治療PRP and platelet-derivedJoints and musculoskeletalClass II
自家多血小板血漿(Platelet-rich plasma:PRP)を用いた関節内組織損傷に対する治療PRP and platelet-derivedJoints and musculoskeletalClass II
自家多血小板血漿(Platelet-rich plasma:PRP)を用いた腱付着部炎・腱障害・筋損傷・関節外靭帯損傷治療PRP and platelet-derivedJoints and musculoskeletalClass III
Joints and musculoskeletal 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家多血小板血漿(Arthrex ACP Double Syringe Systemにより作製)、自家多血小板血漿(ACP MAX PRPシステムにより作製)、または自家多血小板血漿(Angel cPRPシステムにより作製)+ヒアルロン酸併用療法を用いた関節内組織損傷に対する治療PRP and platelet-derivedJoints and musculoskeletalClass II
自家多血小板血漿(Platelet-rich plasma:PRP)を用いた関節内組織損傷に対する治療PRP and platelet-derivedJoints and musculoskeletalClass II
自家多血小板血漿(Platelet-rich plasma:PRP)を用いた腱付着部炎・腱障害・筋損傷・関節外靭帯損傷治療PRP and platelet-derivedJoints and musculoskeletalClass III

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 特定非営利活動法人先端医療推進機構 特定認定再生医療等委員会名古屋
  • 国立大学法人弘前大学認定再生医療等委員会

Public document number

  • 03B2607015
  • 03B2606001
  • 03B2506002
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自家多血小板血漿(Arthrex ACP Double Syringe Systemにより作製)、自家多血小板血漿(ACP MAX PRPシステムにより作製)、または自家多血小板血漿(Angel cPRPシステムにより作製)+ヒアルロン酸併用療法を用いた関節内組織損傷に対する治療Class IIJSCSF再生医療等委員会03B2607015
自家多血小板血漿(Platelet-rich plasma:PRP)を用いた関節内組織損傷に対する治療Class II特定非営利活動法人先端医療推進機構 特定認定再生医療等委員会名古屋03B2606001
自家多血小板血漿(Platelet-rich plasma:PRP)を用いた腱付着部炎・腱障害・筋損傷・関節外靭帯損傷治療Class III国立大学法人弘前大学認定再生医療等委員会03B2506002

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor